Breaking News Instant updates and real-time market news.

ZUO

Zuora

$20.57

0.56 (2.80%)

05:17
11/30/18
11/30
05:17
11/30/18
05:17

Zuora easily exceeded Q3 expectations on all metrics, says Jefferies

Jefferies analyst John DiFucci says Zuora easily exceeded fiscal Q3 expectations across all metrics and raised guidance for fiscal 2019 on the back of improving net retention and strong underlying business momentum. Further, he believes the company's net retention has improved to enterprise class, "even with material exposure to emerging businesses associated with the Subscription Economy." The analyst maintains a Buy rating on the shares with a $35 price target.

  • 06

    Dec

  • 11

    Dec

  • 11

    Dec

  • 12

    Dec

ZUO Zuora
$20.57

0.56 (2.80%)

10/16/18
FBNS
10/16/18
INITIATION
Target $25
FBNS
Outperform
Zuora initiated with an Outperform at FBN Securities
FBN Securities initiated Zuora with an Outperform and $25 price target.
08/31/18
JEFF
08/31/18
NO CHANGE
Target $35
JEFF
Buy
Zuora price target raised to $35 from $28 at Jefferies
Jefferies analyst John DiFucci raised his price target for Zuora to $35 saying the company's Q2 results are strong both "on the surface and under the covers." Subscription revenue grew 44% and the analyst estimates new subscription annual contract value grew at a greater rate. DiFucci, who admits he didn't like the skit-based delivery on the conference call, keeps a Buy rating on Zuora shares.
08/29/18
NEED
08/29/18
NO CHANGE
Target $38
NEED
Buy
Zuora price target raised to $38 from $33 at Needham
Needham analyst Scott Berg raised his price target on Zuora to $38 and kept his Buy rating ahead of its Q2 earnings tomorrow, saying he expects "positive surprises" given his analysis of industry trends in the quarter. The analyst also notes positive feedback that he heard from Zuora's customers and partners at its recent customer conference, which suggests that demand is at least in line with its recent results. Berg believes that Zuora's billings growth could exceed 30% again and sees its premium valuation justified by its total addressable market opportunity.
08/06/18
MSCO
08/06/18
NO CHANGE
MSCO
Boeing, Tesla, Nvidia make Morgan Stanley 'key man risk' list
Morgan Stanley equity strategist Mark Savino noted that about 12% of CEO jobs among S&P 500 companies turned over in 2017, noting that this was the highest level of CEO departures since before the financial crisis. The 59 stocks of S&P 500 companies that had CEOs depart in 2017 underperformed the market by 11% over the next 12 months, or since the departure for instances that were less than 12 months ago, noted Savino. In cooperation with the firm's U.S. analysts, Savino and his team identified the companies in each sector they believe face the greatest level of "key man risk," which includes: Boeing (BA), Tesla (TSLA), ADT Inc. (ADT), Moody's (MCO), TransUnion (TRU), Arista Networks (ANET), Church & Dwight (CHD), Coca-Cola (KO), Monster Beverage (MNST), Coupa Software (COUP), Salesforce (CRM), FireEye (FEYE), MongoDB (MDB), Microsoft (MSFT), New Relic (NEWR), XPO Logistics (XPO), Hilton (HLT), Las Vegas Sands (LVS), Best Buy (BBY), Ulta (ULTA), Aflac (AFL), Athene Holding (ATH), Lincoln National (LNC), Arthur J. Gallagher (AJG), Chubb (CB), Amazon.com (AMZN), Activision Blizzard (ATVI), Facebook (FB), Alphabet (GOOGL), Apple (AAPL), Terex (TEX), Cleveland-Cliffs (CLF), Freeport McMoRan (FCX), FleetCor (FLT), Global Payments (GPN), Square (SQ), Jazz Pharmaceuticals (JAZZ), Cheesecake Factory (CAKE), Broadcom (AVGO), Nvidia (NVDA), Chegg (CHGG), DXC Technology (DXC), Medidata (MDSO), Pluralsight (PS), RealPage (RP), Shopify (SHOP) and T-Mobile (TMUS).

TODAY'S FREE FLY STORIES

CYDY

CytoDyn

$0.00

(0.00%)

08:39
11/18/19
11/18
08:39
11/18/19
08:39
Hot Stocks
CytoDyn engages LifeSci Public Relations as communications partner »

CytoDyn announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HIIQ

Health Insurance Innovations

$23.39

0.31 (1.34%)

08:38
11/18/19
11/18
08:38
11/18/19
08:38
Downgrade
Health Insurance Innovations rating change  »

Health Insurance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IMBI

iMedia Brands

$0.64

0.0001 (0.02%)

08:38
11/18/19
11/18
08:38
11/18/19
08:38
Hot Stocks
iMedia Brands to launch Bulldog shopping network on November 22 »

iMedia Brands announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 03

    Dec

ESTC

Elastic

$74.06

1.94 (2.69%)

08:37
11/18/19
11/18
08:37
11/18/19
08:37
Upgrade
Elastic rating change  »

Elastic upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Dec

AON

Aon plc

$198.67

0.01 (0.01%)

08:37
11/18/19
11/18
08:37
11/18/19
08:37
Downgrade
Aon plc rating change  »

Aon plc downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NOW

ServiceNow

$259.91

6.14 (2.42%)

08:37
11/18/19
11/18
08:37
11/18/19
08:37
Hot Stocks
ServiceNow appoints Gina Mastantuono as CFO, says CEO has assumed role »

ServiceNow announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 09

    Dec

  • 12

    Dec

CTL

CenturyLink

$14.98

0.09 (0.60%)

, INFN

Infinera

$6.70

0.34 (5.35%)

08:36
11/18/19
11/18
08:36
11/18/19
08:36
Hot Stocks
CenturyLink, Infinera bring terabit capacity to supercomputing network »

CenturyLink (CTL) and…

CTL

CenturyLink

$14.98

0.09 (0.60%)

INFN

Infinera

$6.70

0.34 (5.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 09

    Dec

CPA

Copa Holdings

$106.77

-1.94 (-1.78%)

08:36
11/18/19
11/18
08:36
11/18/19
08:36
Recommendations
Copa Holdings analyst commentary  »

Copa Holdings price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

MMC

Marsh & McLennan

$105.50

0.16 (0.15%)

08:35
11/18/19
11/18
08:35
11/18/19
08:35
Upgrade
Marsh & McLennan rating change  »

Marsh & McLennan…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TMUS

T-Mobile

$78.05

1.18 (1.54%)

08:35
11/18/19
11/18
08:35
11/18/19
08:35
Hot Stocks
Breaking Hot Stocks news story on T-Mobile »

T-Mobile down 1.6% after…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

  • 18

    Nov

  • 09

    Dec

TMUS

T-Mobile

$78.05

1.18 (1.54%)

08:35
11/18/19
11/18
08:35
11/18/19
08:35
Earnings
T-Mobile appoints Mike Sievert as CEO effective May 1 »

T-Mobile announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

  • 18

    Nov

  • 09

    Dec

RCAR

RenovaCare

$0.00

(0.00%)

, EMIS

Emisphere Tech

$0.00

(0.00%)

08:35
11/18/19
11/18
08:35
11/18/19
08:35
Hot Stocks
RenovaCare appoints Alan Rubino as president, CEO »

RenovaCare (RCAR)…

RCAR

RenovaCare

$0.00

(0.00%)

EMIS

Emisphere Tech

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTFT

Future FinTech

$0.61

-0.067 (-9.97%)

08:34
11/18/19
11/18
08:34
11/18/19
08:34
Hot Stocks
Future FinTech announces agreement with Chifeng Supply and Marketing Company »

Future FinTech announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JCP

J.C. Penney

$1.18

0.075 (6.82%)

08:34
11/18/19
11/18
08:34
11/18/19
08:34
Recommendations
J.C. Penney analyst commentary  »

Deutsche Bank stays on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNP

CenterPoint Energy

$25.48

-1.2 (-4.50%)

08:33
11/18/19
11/18
08:33
11/18/19
08:33
Downgrade
CenterPoint Energy rating change  »

CenterPoint Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HRI

Herc Holdings

$50.03

0.2 (0.40%)

08:33
11/18/19
11/18
08:33
11/18/19
08:33
Hot Stocks
Herc Holdings appoints Wade Sheek as chief legal officer »

Herc Holdings announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

WY

Weyerhaeuser

$29.35

0.03 (0.10%)

08:32
11/18/19
11/18
08:32
11/18/19
08:32
Recommendations
Weyerhaeuser analyst commentary  »

Weyerhaeuser price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENLV

Enlivex Therapeutics

$8.45

0.15 (1.81%)

08:32
11/18/19
11/18
08:32
11/18/19
08:32
Hot Stocks
Enlivex Therapeutics completes recruitment in Phase Ib trial of Allocetra »

Enlivex Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TMUS

T-Mobile

$78.05

1.18 (1.54%)

08:32
11/18/19
11/18
08:32
11/18/19
08:32
Hot Stocks
Breaking Hot Stocks news story on T-Mobile »

T-Mobile appoints Mike…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

  • 18

    Nov

  • 09

    Dec

AMRS

Amyris

$3.85

-0.03 (-0.77%)

08:32
11/18/19
11/18
08:32
11/18/19
08:32
Hot Stocks
Amyris moves into regulatory stage with new health and nutrition molecule »

Amyris announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

TSLA

Tesla

$352.22

2.71 (0.78%)

08:31
11/18/19
11/18
08:31
11/18/19
08:31
Recommendations
Tesla analyst commentary  »

Tesla price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRBP

Corbus Pharmaceuticals

$4.45

0.15 (3.49%)

08:30
11/18/19
11/18
08:30
11/18/19
08:30
Hot Stocks
Corbus Pharmaceuticals completes enrollment of Phase 2b study of lenabasum »

Corbus Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BPL

Buckeye Partners

$0.00

(0.00%)

, GSL

Global Ship Lease

$7.60

0.09 (1.20%)

08:30
11/18/19
11/18
08:30
11/18/19
08:30
Options
Twelve option delistings on November 18th »

Option delistings…

BPL

Buckeye Partners

$0.00

(0.00%)

GSL

Global Ship Lease

$7.60

0.09 (1.20%)

HOV

Hovnanian

$23.87

0.14 (0.59%)

HPJ

Highpower International

$0.00

(0.00%)

ONCT

Oncternal Therapeutics

$6.09

0.12 (2.01%)

SLRX

Salarius Pharmaceuticals

$3.65

-0.05 (-1.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COO

Cooper Companies

$301.97

2.64 (0.88%)

08:29
11/18/19
11/18
08:29
11/18/19
08:29
Hot Stocks
Cooper Companies announces FDA approval of MiSight for treatment of myopia »

CooperCompanies announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

AMD

AMD

$38.55

0.19 (0.50%)

08:28
11/18/19
11/18
08:28
11/18/19
08:28
Recommendations
AMD analyst commentary  »

AMD price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 09

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.